News & Updates

Original New Drug Application Approvals by US FDA (1-15 March 2024)

Pembrolizumab effective against mucosal melanoma and bladder cancer

Findings of two studies presented recently at the European Cancer Congress 2017 (ECCO 2017) demonstrates the effect of the PD-1 inhibitor, pembrolizumab, against a rare form of melanoma and bladder cancer. 

Sequential fosfomycin therapy beneficial in bacterial prostatitis caused by multidrug-resistant E coli

Sequential treatment with the oral antibiotic fosfomycin appears to be safe and effective in the management of patients with acute bacterial prostatitis secondary to multidrug-resistant Escherichia coli, according to the phase IV FOS-PROST study.

AI algorithm boasts accuracy in stone volume determination

An automated artificial intelligence (AI) algorithm demonstrates accuracy and efficiency in determining stone volume using computed tomography (CT) scans, as shown in a study.

Conversion from robotic partial to radical nephrectomy driven by anatomic, oncologic complexity

Conversion from robotic partial to radical nephrectomy is low among patients with a renal mass, while that due to uncontrolled bleeding is even lower, according to a study.

Intravesical interferon a promising treatment option for interstitial cystitis

Intravesical interferon instillation appears to benefit women with interstitial cystitis (IC), with a recent study showing that the approach helps improve patient-reported and objective outcomes compared with hyaluronic acid without serious adverse events.